Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7734955

Concept As at
2017-06-30
2017-04-01 to
2017-06-30
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-06-30
2016-04-01 to
2016-06-30
Key financial data of group
Business results of group
Net sales
24,967,000,000 JPY
101,479,000,000 JPY
26,228,000,000 JPY
Ordinary profit (loss)
7,813,000,000 JPY
30,981,000,000 JPY
8,217,000,000 JPY
Profit (loss) attributable to owners of parent
5,463,000,000 JPY
22,017,000,000 JPY
5,796,000,000 JPY
Comprehensive income
6,300,000,000 JPY
22,587,000,000 JPY
5,158,000,000 JPY
Net assets
104,101,000,000 JPY
102,655,000,000 JPY
90,053,000,000 JPY
Total assets
138,909,000,000 JPY
135,060,000,000 JPY
129,410,000,000 JPY
Basic earnings (loss) per share
133.81
536.70
140.05
Diluted earnings per share
Equity-to-asset ratio
0.749 xbrli:pure
0.760 xbrli:pure
0.696 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.